Status:
COMPLETED
Naldebain for Pain Management of Laparoscopic Cholecystectomy
Lead Sponsor:
E-DA Hospital
Conditions:
Pain, Postoperative
Pain, Chronic
Eligibility:
All Genders
20-65 years
Phase:
PHASE2
PHASE3
Brief Summary
Laparoscopic cholecystectomy is the most common surgical procedure for removal of the inflamed gall bladder or other gall bladder pathologies. There are more than 12,000 cases of cholecystectomy perfo...
Detailed Description
Clinical studies indicate that more than 80% of patients suffer from surgical-related pain in the first few days after major laparotomy or laparoscopic abdominal surgery and about 10% of these patient...
Eligibility Criteria
Inclusion
- Patient scheduled to receive laparoscopic cholecystectomy
Exclusion
- Emergency operation
- Open cholecystectomy
- American Society of Anesthesiologists physical status \> or =4
- Chronic opioid user
- Allergy to nalbuphine, benzyl benzoate or sesame oil
- Anticipated to receive ventilator support via an endotracheal tube after operation
- Unable for verbal pain assessment or not able to participate questionnaire survey
Key Trial Info
Start Date :
August 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 18 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04808544
Start Date
August 30 2021
End Date
April 18 2022
Last Update
April 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
E-Da Hospital
Yanchao, Kaohsiung, Taiwan, 824